The aim of this study was to determine whether polymorphisms of the glucocorticoid receptor gene, influencing glucocorticoid sensitivity, are associated with persistent nasal carriage of Staphylococcus aureus. Two nasal swab cultures were obtained from each of 2929 participants. Subjects were classified as persistent carriers ( ) if both cultures were positive. GG homozygotes of the exon 9b polymorphism were associated with n p 563 a 68% reduced risk of persistent S. aureus nasal carriage, whereas carriers of the codon 23 lysine allele displayed an 80% increased risk. Thus, genotype-dependent variation in the sensitivity to glucocorticoids is associated with tolerance toward staphylococcal nasal colonization.
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The anterior nares are the primary ecological reservoir of Staphylococcus aureus in humans, and S. aureus nasal carriage is a major risk factor for a variety of infections [1] . Three human nasal S. aureus carriage patterns can be distinguished: persistent carriage, intermittent carriage, and noncarriage. S. aureus density in the anterior nares is highest in persistent carriers [2] , which may explain their increased risk of developing S. aureus infections. Variation among colonizing strains is higher for intermittent carriers, suggesting that the basic host determinants of persistent and intermittent carriage are different. The biology of nasal colonization with S. aureus remains incompletely understood. A variety of bacterial factors have been deemed important for the maintenance of colonization of the human nasal cavity by S. aureus. Besides polysaccharides, proteins belonging to the group of microbial surface components recognizing adhesive-matrix molecules play a role in bacterial adhesion [1] . In addition, environmental factors, as well as host factors of the immune status, are thought to play a pivotal role in determining the S. aureus nasal carrier state [3] .
Immune suppression by glucocorticoids is well known in the treatment of many inflammatory and autoimmune diseases or organ transplantation. The general cortisol status of individuals has been suggested as an important determinant of infection susceptibility. Glucocorticoids repress a large number of proinflammatory cytokines, activate a number of anti-inflammatory genes, and up-regulate cell-adhesion molecules such as intercellular adhesion molecule 1 [4] , although downregulation of neutrophil-adhesion molecules has also been documented [5] . The ability of S. aureus to evade the immune response of the host by surviving inside neutrophils has been shown to be a virulence factor [6] . Impaired phagocytic activity is probably also a central factor in determining S. aureus nasal carriage [7] . Several glucocorticoid receptor (GR) gene polymorphisms are thought to be functional and have been described as associated with variation in glucocorticoid sensitivity, variation in insulin sensitivity, changes in body fat distribution, and autoimmune diseases such as rheumatoid arthritis [8, 9] . Consequently, changes in glucocorticoid sensitivity may predispose to or protect from microbial colonization or infection on the one hand or autoimmune disease on the other.
We searched for host immunogenetic markers for S. aureus nasal carriage. In the present study, we aimed to determine whether the 4 known functional polymorphisms of the GR gene are associated with persistent S. aureus nasal carriage.
MATERIAL AND METHODS
Study population. This study was conducted as part of the Rotterdam Study, a prospective, population-based cohort study of determinants of disease and disability in elderly persons, started in Rotterdam, The Netherlands, in 1990 with 7983 participants [10] . The second follow-up of this study was performed between 1 April 1997 and 31 December 1999 with 4797 remaining participants. No selection was applied to these subjects. The Medical Ethics Committee of the Erasmus Medical Center approved the study. Informed consent was obtained from all participants. Two quantitative S. aureus-specific nasal swab cultures were performed at 1-week intervals [2] . We obtained complete bacteriological results in 3851 persons (2224 women and 1627 men). Subjects were classified as persistent carriers ( ) if both cultures were positive. Those with both culn p 678 tures negative were classified as noncarriers ( ) [2] . n p 2804 Genotyping. All participants were genotyped for 4 known functional GR gene polymorphisms. We used the genotype data for each of the 4 polymorphisms to infer the haplotypes, on the basis of Bayesian linkage disequilibrium analyses [11] (figure 1) . For each haplotype, 3 genotype combinations were distinguished, with 0, 1, or 2 copies of the haplotype allele (figure 1). Haplotype 2 is characterized by the G allele of the Bcl1 polymorphism, identified as an intronic CrG nucleotide substitution (no rs number) 646 nt downstream from exon 2 [12] . Haplotype 3 is characterized by the G allele of the nucleotide substitution located in the 3 end of exon 9b, which encodes for the 3 untranslated region of the mRNA of the hGRb isoform (nt 3669 in X03348; rs6198 in the dbSNP database [available at: http://www.ncbi.nlm.nih.gov/SNP]) [13] .
Haplotype 4 is characterized by the G allele of the N363S polymorphism of exon 2 (nt 1220 in NM_000176; rs6195), located in the transactivation domain [14] . Haplotype 5 is characterized by the A allele of the ER22/23EK polymorphism, which is a combination of 2 linked single-nucleotide variations in codons 22 and 23 (nt 198 and 200; rs6189 and rs6190, respectively), leading to an arginine-to-lysine change in codon 23 in the transactivation domain [8] , in combination with the G allele of the 9b polymorphism that is also present in haplotype 3.
DNA was isolated from peripheral-blood leukocytes by use of standard techniques and was stored at Ϫ20ЊC. Polymerase chain reaction amplification and genotyping were performed using 5 ng of genomic DNA for the Taqman allelic discrimination assay. Primer and probe sequences were optimized using the single-nucletide-polymorphism assay-by-design service of Applied Biosystems. For details, see the Applied Biosystems Products and Services Web page (available at: https://products .appliedbiosystems.com/ab/en/US/adirect/ab). Reactions were 
Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs). Results with 2-sided P values of !.05 were considered to be statistically significant.
RESULTS
For 2929 participants, a complete data set on S. aureus nasal carrier state, confounding variables, and all GR gene polymorphisms was available. Median age was 72 years, 58% were women, 18% were current and 48% past smokers, and mean fasting glucose was 5.9 mmol/L (table 1). These baseline characteristics were not significantly different from those for the complete Rotterdam Study cohort. Prevalence of persistent S. aureus nasal carriage in the final cohort was 19.2% (563/2929).
In S. aureus noncarriers, the distribution of genotypes for all individual GR gene polymorphisms were in Hardy-Weinberg equilibrium ( ) (table 2) . The frequencies of haplotype P 1 .05 alleles 1-5 were 41.9%, 36.5%, 14.5%, 3.7%, and 3.4%, respectively ( figure 1) . No associations were found between GR haplotypes and the covariates age, sex, smoking, eczema, and fasting serum glucose levels.
Genotypes defined by carrier status for haplotypes 2 and 4 showed no significant difference in the prevalence of S. aureus nasal carriage. Analysis of the association of the 5 GR haplotypes revealed that haplotype 3 was significantly ( ) P p .020 associated with a lower prevalence of S. aureus nasal carriage with evidence for a recessive effect. After correction for age, sex, smoking, eczema, and fasting serum glucose levels by logistic regression analyses, this association remained essentially unchanged ( nasal carriage by 80% (OR, 1.80 [95% CI, 1.08-3.00]). No direct relation was found between fasting blood glucose levels and any of the haplotypes investigated.
DISCUSSION
Our study suggests for the first time that human DNA polymorphisms such as those found in the GR gene are significantly associated with S. aureus nasal-carriage status. The 4 GR gene polymorphisms that we studied have all been associated with variation in glucocorticoid sensitivity [8] . Haplotype 2, found elsewhere to be associated with increased glucocorticoid sensitivity [12] , was not associated with S. aureus carrier status.
We found that homozygous presence of haplotype 3 conferred a 68% lower risk of persistent S. aureus nasal carriage. This G allele of the exon 9b polymorphism is overrepresented in a group of patients with rheumatoid arthritis [9] . The mechanism for this is unknown, but stabilization of the GRb mRNA by the presence of this G allele-as has indeed been observed in vitro [9, 13] -may play a role. The G allele has an interrupted mRNA destabilizing ATTTA motif, resulting in a higher stability for the GRb mRNA. This stabilization induces relative glucocorticoid insensitivity through accumulation of the GRb protein, which has been reported to have a dominant negative influence on GRa action [9, 13] . This, in turn, may lead to an immune enhancement predisposing to chronic autoimmune inflammatory disease, such as rheumatoid arthritis, while protecting from S. aureus colonization. Although no data on insulin sensitivity or tissue glucose concentrations are available for the population studied, the lack of association between fasting blood glucose and the exon 9b polymorphism suggests that a reduced glucocorticoid-induced immune suppression is the most likely explanation for the association observed here.
Haplotype 4 has been shown to increase glucocorticoid sensitivity [14] . It was, however, not associated with S. aureus carriage. Haplotype 5 has been associated with increased resistance to glucocorticoids, higher cortisol levels after dexamethasone-suppression testing, lower fasting insulin concentrations, and better insulin sensitivity [8] . We found that carriers of this haplotype allele were at an increased risk of persistent S. aureus carriage. Persons with the genotypic combination of haplotype 1 and this haplotype allele had an 80% higher risk of persistent S. aureus carriage than did all other genotypes (OR, 1.8 [95% CI, 1.08-3.00]). Haplotype 5 carriers show a relative glucocorticoid resistance due to less transactivation in combination with normal transinhibition of the proinflammatory nuclear factor NF-kB [15] . We hypothesize that the higher cortisol levels in these carriers lead to an increased transinhibition and thus to suppression of the immune system. It should be noted that, in haplotype 5 (with increased risk of S. aureus carriage), the ER2223EK polymorphism is combined with the G variant of 9b, whereas a protective effect of this G allele 9b variant was seen in homozygotes for haplotype 3. This suggests a recessive effect of the 9b G allele. Second, all 5 23-lysine homozygotes were noncarriers of S. aureus, which might be due to the fact that they were also homozygous for the 9b G allele.
The current availability of sophisticated high-throughput genotyping technologies, in combination with the availability of a large, prospective, population-based epidemiologic survey, has provided a unique opportunity to study genetic determinants of S. aureus nasal carriage. The limitation is that our study has a descriptive nature, and future research should lead to better insight into the underlying mechanisms. In addition, our study population was elderly (155 years old) and 198% white. Therefore, results might not apply to groups of different genetic or environmental backgrounds. Furthermore, little is known about the physiological effects of the GR gene polymorphisms. It was recently demonstrated that glucocorticoids, in conjunction with proinflammatory cytokines, affect the expression of Toll-like receptors, the main pattern-recognition molecules for gram-positive pathogens such as S. aureus [16] . Whether the various GR gene polymorphisms studied here are (partially) defective in supporting this biological activity is currently unknown but, again, warrants further investigation. Our data suggest that genetic variation in the GR gene affects persistent S. aureus nasal carriage. Further investigations would form a new field of research focusing on S. aureus carriage and glucocorticoid/GR gene-dependent innate immune determinants. Genotype-dependent variation in sensitivity to glucocorticoids seems to influence the individual status of immune suppression. These immunomodulatory properties of glucocorticoid hormones may be important in the prevention and treatment of many diseases.
